EP1182982A1 - Selbstabnehmbare energieabsorbierende struktur zur thermischen gewebeablation - Google Patents

Selbstabnehmbare energieabsorbierende struktur zur thermischen gewebeablation

Info

Publication number
EP1182982A1
EP1182982A1 EP00939642A EP00939642A EP1182982A1 EP 1182982 A1 EP1182982 A1 EP 1182982A1 EP 00939642 A EP00939642 A EP 00939642A EP 00939642 A EP00939642 A EP 00939642A EP 1182982 A1 EP1182982 A1 EP 1182982A1
Authority
EP
European Patent Office
Prior art keywords
tissue
aperture
energy
film layer
absorbent film
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00939642A
Other languages
English (en)
French (fr)
Inventor
Jonathan A. Eppstein
Stuart Mcrae
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Altea Therapeutics Corp
Spectrx Inc
Original Assignee
Spectrx Inc
Altea Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spectrx Inc, Altea Technologies Inc filed Critical Spectrx Inc
Publication of EP1182982A1 publication Critical patent/EP1182982A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/203Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser applying laser energy to the outside of the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B18/28Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor for heating a thermal probe or absorber
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/0045Devices for taking samples of body liquids
    • A61B2010/008Interstitial fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743Type of operation; Specification of treatment sites
    • A61B2017/00747Dermatology
    • A61B2017/00765Decreasing the barrier function of skin tissue by radiated energy, e.g. using ultrasound, using laser for skin perforation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00452Skin

Definitions

  • This invention relates to the field of tissue ablation for the formation of openings in the tissue.
  • this invention relates to self-removing energy absorbing structures for achieving thermal tissue ablation.
  • the flux of a drug or analyte across a biological tissue can be increased by changing the diffusion coefficient or the gradient for diffusion. Commonly, the flux is enhanced by increasing the permeability of the skin, such as by chemical penetration enhancers, iontophoresis, and poration techniques.
  • Thermal tissue ablation for forming openings in tissue is disclosed in commonly assigned U.S. Patent No. 5,885,211 to Eppstein, et al. There is room for improving the thermal tissue ablation process.
  • the present invention is directed to a device to facilitate ablation of tissue, such as for forming one or more openings in the tissue for transdermal monitoring and/or delivery applications.
  • the device comprises: (a) a support layer having at least one aperture therein, and (b) at least one energy absorbent film layer disposed over at least one aperture in the support layer for making substantial contact with tissue through the aperture.
  • the at least one energy absorbent film layer is under a tension force over or across the aperture and absorbs energy focused thereon to thermally ablate the tissue. After ablation, and because it is under tension, the film layer breaks apart allowing access to the ablated tissue beneath it.
  • the present invention is further directed at a method for forming openings in a tissue comprising the steps of: (a) positioning a support layer having an aperture therein on a tissue; (b) positioning an energy absorbent film layer over the aperture to make substantial contact with the tissue through the aperture; and (c) focusing energy onto the energy absorbent film layer to conduct heat to the tissue thereby ablating the tissue.
  • Figure 1 is a perspective view of one embodiment of a portion of the device of the present invention.
  • Figure 2 is cross-sectional view taken through line A-A of Figure 1 and illustrating the relationship of the energy absorbent film to the tissue when suction is applied to the device.
  • Figure 3 is a top view of one embodiment of a portion of the device showing the energy absorbent film before it has been affected by energy.
  • Figure 4 is a top view of one embodiment of a portion of the device showing the energy absorbing layer after it has been affected by energy.
  • Figure 5 is a top view of one embodiment of a portion of the device used as part of a transdermal delivery system.
  • Figure 6 is a top view of one embodiment of a portion of the device used as part of a monitoring system.
  • opening means any size hole, aperture or pore of any depth, that is capable of substance transport therethrough.
  • Inclusive in this term is at least one opening in the tissue sized no larger than about 1000 ⁇ m in diameter called a micropore.
  • the device 100 includes at least a support layer 7 and an energy absorbent film layer 25. Depending on the application of the device 100, it also includes an optional assay reagent pad 20.
  • the energy absorbent film layer 25 is stretched or otherwise placed under tension across a hole or aperture 40 in the support layer 7.
  • At least one hole or aperture 35 is provided in the assay reagent pad 20 above the hole 40 and the energy absorbent film 25.
  • the hole(s) 35 may be any shape or size to provide a suitable site for tissue ablation.
  • the energy absorbent film layer 25 of Figure 1 is held in place and under tension across the aperture 40 by at least one tension member 30.
  • This tension member(s) 30 may be constructed of any suitable material in any shape to create a tension force across the film 25.
  • at least one tension member 30 is provided at one end of the energy absorbent film layer 25 and the other end is fixed to the support layer 7 by other suitable means, such as by glue or spot weld attachment.
  • at least one tension member 30 is provided at both ends of the energy absorbent film layer 25 to hold it under tension across the aperture 40.
  • materials suitable for the tension member(s) 30 include elastic, rubber, metal springs, or plastic springs or the like.
  • tension members 30 are not needed and the film 25 is anchored directly to the support layer 7.
  • Such anchoring may be performed by any suitable means including adhesive bonding, electromagnetic bonding, hot plate welding, induction bonding, insert bonding, radio-frequency sealing, spot welding, thermostacking, chemical bonding, thermo bonding, vibration welding or ultrasonic welding.
  • film 25 suitable for such use without tension members include pre-stretched mylar, rubber, silicone, polycarbonate, polyurethane, polyvinyl chloride, or polypropylene film.
  • the support layer 7 serves to support the film 25 across the aperture 40.
  • suitable materials for the support layer 7 include polyester, ceramic, polycarbonate (PC), polyvinylchloride (PVC), and mixtures thereof.
  • This support layer can be of any suitable thickness to maintain structural support for the film 25.
  • the optional assay reagent pad 20 serves to detect the presence of a substance in the fluid.
  • the assay reagent pad 20 may be useful in detecting the presence of an analyte (such as glucose) in blood or interstitial fluid.
  • the assay reagent pad 20 may be constructed of any suitable material, with as many layers or materials as necessary for detecting the presence of a substance in a fluid. Elements of the assay reagent pad include electrodes, one or more enzymes, and one or more indicators as is well known in the electrochemical biosensor art.
  • the assay reagent pad 20 alternatively may be a type that is optically interrogated to determine a measurement of an analyte.
  • the assay reagent pad 20 may be attached to the film 25 or may be placed proximate to the film 25 such that the pad 20 is capable of fluid communication with the film 25.
  • the energy absorbent film layer 25 includes a layer of material that absorbs energy and heats up. As the energy absorbent film layer 25 is heated by a beam or field 10 of energy, the film 25 transfers heat to the tissue by conduction, thereby ablating the tissue. One use of ablating the tissue is to form one or more openings in the tissue for transdermal monitoring or delivery applications. Thermal tissue ablation for forming openings is described more fully in U.S. Patent No. 5,885,211. Any suitable energy may be used for the beam of energy 10 to heat the energy absorbent film 25. In one embodiment, the beam of energy 10 is a beam of optical energy, which may for example be provided by a laser diode.
  • the energy 10 is comprised of electromagnetic energy, laser, gamma radiation, and/or beta radiation, etc.
  • the types of energy absorbing substances that are suitable for the film 25 include those disclosed in commonly assigned U.S. Patent No. 5,885,211, and in commonly assigned PCT/0599/04929, filed March 5, 1999, both of which are incorporated herein by reference in their entireties.
  • Copper pythalocyanine doped film is an example of a suitable film 25 material.
  • a clear film 25 with an absorbent adhesive layer can be used whereby the adhesive provides a positive attachment to the targeted tissue, and a thermal conduction path to the tissue.
  • a vacuum or suction 15 is applied (by a vacuum source not shown) to a region 27 of the device 100 so as to pull the tissue 5 up to contact the film 25 through the aperture 40 of the support layer 7 ( Figure 2).
  • the film 25 flexes to provide good physical contact with the underlying tissue 5 which is desirable to achieve efficient transfer of heat to the tissue when the energy absorbent film layer 25 is heated.
  • the beam or field 10 of energy is then directed onto the energy absorbent film 25.
  • the film 25 heats up and the heat in the film is transferred by conduction to the tissue 5, thereby ablating the tissue.
  • the film 25 absorbs the energy and transfers it to the tissue, eventually, because of the tension force, it breaks and separates across the aperture 40 as illustrated in Figure 4.
  • the film 25 burns up as the thermal ablation process occurs and in so doing is weakened to be overcome by the tension force.
  • This self-removal or self-separating feature of the film 25 allows access to the ablated area of the tissue to facilitate fluid communication with the opening(s) 45 without any additional steps.
  • Figure 5 depicts the device 100 used in connection with a transdermal delivery system wherein at least one drug or agent is delivered to the tissue 5 via the opening(s) in the tissue 45.
  • a reservoir 70 containing the at least one drug or agent may be in fluid communication with the opening(s) in the tissue 45 via a conduit 60, such as tubing.
  • the reservoir 70 may be integrally formed with the support layer 7 so that the at least one drug or agent can be delivered into the tissue 5 in a single step procedure with gravity or pressure forcing the drugs or agents into the tissue 5.
  • Figure 6 shows the device 100 used in connection with a monitoring system.
  • the assay reagent pad 20 may be located on the device 100 and connected (wired or wirelessly) to a monitoring apparatus 200.
  • the assay reagent pad 20 may be located remotely in the monitoring apparatus 200 and coupled via fluid conduit 60 that carries the fluid.
  • the assay reagent pad 20 is located remote or proximate to the opening(s) in the tissue 45 depends on the specific application. Both embodiments are useful in discrete monitoring applications for analyzing fluid on a single use basis, as well as in continuous monitoring applications for continuously extracting and analyzing fluid over a longer term basis, such as several hours, days, etc. See, for example, International Application No. PCT US99/16378, filed July 20, 1999, entitled “System and Method for Continuous Analyte Monitoring".
EP00939642A 1999-06-09 2000-06-07 Selbstabnehmbare energieabsorbierende struktur zur thermischen gewebeablation Withdrawn EP1182982A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13819399P 1999-06-09 1999-06-09
US138193P 1999-06-09
PCT/US2000/015665 WO2000074583A1 (en) 1999-06-09 2000-06-07 Self-removing energy absorbing structure for thermal tissue ablation

Publications (1)

Publication Number Publication Date
EP1182982A1 true EP1182982A1 (de) 2002-03-06

Family

ID=22480890

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00939642A Withdrawn EP1182982A1 (de) 1999-06-09 2000-06-07 Selbstabnehmbare energieabsorbierende struktur zur thermischen gewebeablation

Country Status (3)

Country Link
EP (1) EP1182982A1 (de)
AU (1) AU5469900A (de)
WO (1) WO2000074583A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6517532B1 (en) 1997-05-15 2003-02-11 Palomar Medical Technologies, Inc. Light energy delivery head
CA2323479A1 (en) 1998-03-12 1999-09-16 Palomar Medical Technologies, Inc. System for electromagnetic radiation of the skin
US20040147984A1 (en) * 2001-11-29 2004-07-29 Palomar Medical Technologies, Inc. Methods and apparatus for delivering low power optical treatments
WO2003089043A2 (en) 2002-04-19 2003-10-30 Transpharma Medical Ltd. Handheld transdermal drug delivery and analyte extraction
JP2005535370A (ja) 2002-06-19 2005-11-24 パロマー・メディカル・テクノロジーズ・インコーポレイテッド 皮膚および皮下の症状を治療する方法および装置
CN1771073A (zh) 2003-02-10 2006-05-10 帕洛玛医疗技术公司 发光的口腔用具以及使用方法
US7856985B2 (en) 2005-04-22 2010-12-28 Cynosure, Inc. Method of treatment body tissue using a non-uniform laser beam
US7586957B2 (en) 2006-08-02 2009-09-08 Cynosure, Inc Picosecond laser apparatus and methods for its operation and use
WO2009047774A2 (en) 2007-10-09 2009-04-16 Transpharma Ltd. Magnetic patch coupling
US8281675B2 (en) 2007-10-17 2012-10-09 Syneron Medical Ltd Dissolution rate verification
WO2009072108A2 (en) 2007-12-05 2009-06-11 Syneron Medical Ltd. A disposable electromagnetic energy applicator and method of using it
US8606366B2 (en) 2009-02-18 2013-12-10 Syneron Medical Ltd. Skin treatment apparatus for personal use and method for using same
US9919168B2 (en) 2009-07-23 2018-03-20 Palomar Medical Technologies, Inc. Method for improvement of cellulite appearance
KR102183581B1 (ko) 2012-04-18 2020-11-27 싸이노슈어, 엘엘씨 피코초 레이저 장치 및 그를 사용한 표적 조직의 치료 방법
US10285757B2 (en) 2013-03-15 2019-05-14 Cynosure, Llc Picosecond optical radiation systems and methods of use
CA3092248A1 (en) 2018-02-26 2019-08-29 Mirko Mirkov Q-switched cavity dumped sub-nanosecond laser

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775361A (en) * 1986-04-10 1988-10-04 The General Hospital Corporation Controlled removal of human stratum corneum by pulsed laser to enhance percutaneous transport
US5643252A (en) * 1992-10-28 1997-07-01 Venisect, Inc. Laser perforator
US5885211A (en) * 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
US6027496A (en) * 1997-03-25 2000-02-22 Abbott Laboratories Removal of stratum corneum by means of light
DE69928229T2 (de) * 1998-02-17 2006-08-03 Abbott Laboratories, Abbott Park Gerät zum entnehmen und analysieren von interstitieller flüssigkeit

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0074583A1 *

Also Published As

Publication number Publication date
WO2000074583A1 (en) 2000-12-14
AU5469900A (en) 2000-12-28

Similar Documents

Publication Publication Date Title
US6685699B1 (en) Self-removing energy absorbing structure for thermal tissue ablation
WO2000074583A1 (en) Self-removing energy absorbing structure for thermal tissue ablation
US6925317B1 (en) Integrated alignment devices, system, and methods for efficient fluid extraction, substance delivery and other applications
EP1289588B1 (de) Vorrichtung zum verbessern der penetrierbarkeit eines punktierelementes in den intradermalen raum
EP1059939B1 (de) Vorrichtung zur erhöhung der flüssigkeitsdurchflussgeschwindigkeit in einem biologischen gewebe mit mikroporen
US8814808B2 (en) Body fluid sampling device
EP1059882B1 (de) Integrierte gewebeporations-, flüssigkeitsammel- und analysevorrichtung
US7066884B2 (en) System, method, and device for non-invasive body fluid sampling and analysis
CA2329169C (en) Apparatus for electroporation through microporated tissue
KR100750841B1 (ko) 채취되는 약물의 경피 유동을 강화하기 위한 장치 및 방법
AU757192B2 (en) Device for enhancing transdermal agent flux
US6749575B2 (en) Method for transdermal nucleic acid sampling
EP1725169B1 (de) Vorrichtung zur entnahme von körperflüssigkeit
JP2001505444A (ja) 経皮サンプリングを強めるための装置
EP1185202B1 (de) Ausrichtungsvorrichtungen zur flüssigkeitsgewinnung aus gewebe und zur substanzabgabe
US20040249254A1 (en) Devices, systems and methods for extracting bodily fluid and monitoring an analyte therein
JP2004520103A5 (de)
AU2001283469B2 (en) Method for transdermal nucleic acid sampling
AU2001283469A1 (en) Method for transdermal nucleic acid sampling
KR20000016698A (ko) 경피 샘플링을 향상시키는 장치
MXPA00005765A (en) Device for enhancing transdermal agent flux

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011219

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SPECTRX, INC.

Owner name: ALTEA THERAPEUTICS CORPORATION

17Q First examination report despatched

Effective date: 20040203

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040814